Regeneron Pharmaceuticals, Inc.
(NASDAQ : REGN)

( )
REGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.59%153.580.0%$1235.68m
AMGNAmgen, Inc. 0.00%249.951.3%$706.86m
SNSSSunesis Pharmaceuticals, Inc. 0.00%8.000.7%$559.23m
NVAXNovavax, Inc. -1.11%192.5080.0%$533.69m
ILMNIllumina, Inc. 0.00%403.153.5%$527.32m
GILDGilead Sciences, Inc. -0.45%64.601.0%$470.31m
REGNRegeneron Pharmaceuticals, Inc. 0.27%478.322.7%$432.27m
VRTXVertex Pharmaceuticals, Inc. 0.25%216.481.9%$372.99m
ALXNAlexion Pharmaceuticals, Inc. 0.00%153.732.0%$315.33m
BIIBBiogen, Inc. 0.00%266.191.7%$292.97m
BNTXBioNTech SE 0.28%130.000.0%$219.41m
EXASEXACT Sciences Corp. 1.48%129.8918.4%$197.74m
NBIXNeurocrine Biosciences, Inc. 0.00%92.974.9%$172.50m
CRSPCRISPR Therapeutics AG 0.47%121.450.6%$170.15m
TXG10X Genomics, Inc. 0.00%197.360.0%$149.02m

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.